Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pfizer Inc. (PFE) had Revenue of $13.71B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$13.71B
Net Income	$2.97B
Cost of Goods Sold	$2.85B
Gross Profit	$10.87B
Operating Expenses	$9.98B
Operating Income	$3.74B
Non-Operating Income/Expense	$-953.00M
Pre-Tax Income	$2.79B
Normalized Pre-Tax Income	$2.79B
Income after Taxes	$2.97B
Income from Continuous Operations	$2.97B
Consolidated Net Income/Loss	$2.97B
Normalized Income after Taxes	$2.97B
EBIT	$3.74B
EBITDA	$5.36B
Weighted-Average Shares Outstanding (Basic)	5.67B
Weighted-Average Shares Outstanding (Diluted)	5.71B
Earnings per Share (EPS) (Basic)	$0.52
Earnings per Share (EPS) (Diluted)	$0.52
Balance Sheet Financials
Current Assets	$45.86B
Property, Plant, and Equipment	$18.35B
Long-Term Assets	$162.17B
Total Assets	$208.03B
Current Liabilities	$36.45B
Long-Term Debt	$57.64B
Long-Term Liabilities	$80.94B
Total Liabilities	$117.39B
Common Equity	$90.64B
Tangible Shareholders Equity	$-31.78B
Shareholders Equity	$90.64B
Common Shares Outstanding	5.68B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.33B
Cash Flow from Investing Activities	$3.27B
Cash Flow from Financial Activities	$-5.23B
Beginning Cash	$1.11B
End Cash	$1.48B
Increase/Decrease in Cash	$375.00M
Stock-Based Compensation	$170.00M
Common Stock Dividends Paid	$-2.44B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.39
Debt to Equity Ratio	0.69
Gross Margin	79.26%
Operating Margin	27.25%
EBIT Margin	27.25%
EBITDA Margin	--
Pre-Tax Profit Margin	20.31%
Profit Margin	21.63%
Free Cash Flow	$1.77B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.26
Receiveable Turnover	1.16
Days Sales in Receivables	77.73
Return on Equity	3.28%
Return on Tangible Equity	-9.35%
Return on Assets	1.43%
Return on Investments	2.00%
Book Value Per Share	$15.94
Free Cash Flow per Share	$0.31
Operating Cash Flow per Share	$0.41

Data from Zacks Investment Research, Inc.